Inappropriate antidiuretic hormone secretion after high dose vinblastine.
We report on a patient with an embryonal teratocarcinoma of the testicle who had the syndrome of inappropriate secretion of antidiuretic hormone after receiving a high dose of vinblastine. His clinical course and laboratory studies are discussed. We suggest that patients receiving a high dose of vinblastine are at risk for the development of this syndrome.
D000328:Adult; D006801:Humans; D007177:Inappropriate ADH Syndrome / Q000139:chemically induced*; D008297:Male; D013724:Teratoma / Q000188:drug therapy*; D013736:Testicular Neoplasms / Q000188:drug therapy*; D014747:Vinblastine / Q000009:adverse effects*
D014747:Vinblastine